Latest News about BIO
Recent news which mentions BIO
A Look Into Healthcare Sector Value Stocks
December 21, 2020
From Benzinga
12 Emerging Technologies To Watch In 2021
December 17, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
November 23, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
November 05, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 04, 2020
From Benzinga
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
November 04, 2020
From Benzinga
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
November 03, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 02, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
October 30, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
October 27, 2020
From Benzinga
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
October 25, 2020
From Benzinga
IPO Outlook: Insurance Cos., Mortgage Providers, Leslie's Pool Supplies Highlight This Week's Offerings
October 25, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
October 23, 2020
From Benzinga
The Daily Biotech Pulse: Gilead Gets Full Approval For Remdesivir, Akebia's Positive Readout, Foghorn IPO
October 23, 2020
From Benzinga
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
October 22, 2020
From Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
From Benzinga
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
October 20, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs
October 16, 2020
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
From Benzinga
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
October 14, 2020
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.